Proctitis ulcerosa activa y refractaria: Una puesta al día
Ulcerative colitis (UC) is a chronic inflammatory disease of unknown etiology that affects a variable length of the colon, starting from the rectum. When the disease is confined to the rectum is called ulcerative proctitis (UP). Several studies have unsuccessfully attempted to determine the factors...
Guardado en:
Autores principales: | , , , |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2010
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872010000100016 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0034-98872010000100016 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0034-988720100001000162010-05-10Proctitis ulcerosa activa y refractaria: Una puesta al díaCASELLI M,GINOPINEDO M,GEORGEZÚÑIGA D,ÁLVAROÁLVAREZ L,MANUEL Colitis ulcerative meselamine proctitis Ulcerative colitis (UC) is a chronic inflammatory disease of unknown etiology that affects a variable length of the colon, starting from the rectum. When the disease is confined to the rectum is called ulcerative proctitis (UP). Several studies have unsuccessfully attempted to determine the factors that determine the extent of involvement. The goals of therapy in UP are to induce and maintain remission of symptoms and disease. Topical treatment with 5-aminosalicylates (5-ASA) is the treatment of choice to induce remission. In the maintenance phase, long-term follow up studies suggest that treatment with 5-ASA is better than placebo, to maintain the disease inactive. For those patients that do not respond to treatment with topical 5-ASA or have a moderate to severe disease, there are additional therapies such as oral 5-ASA, topical or systemic corticosteroids, immunomodulators, biological therapies (Infliximab) and cyclosporine. Surgery is seldom needed.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.138 n.1 20102010-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872010000100016es10.4067/S0034-98872010000100016 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
Spanish / Castilian |
topic |
Colitis ulcerative meselamine proctitis |
spellingShingle |
Colitis ulcerative meselamine proctitis CASELLI M,GINO PINEDO M,GEORGE ZÚÑIGA D,ÁLVARO ÁLVAREZ L,MANUEL Proctitis ulcerosa activa y refractaria: Una puesta al día |
description |
Ulcerative colitis (UC) is a chronic inflammatory disease of unknown etiology that affects a variable length of the colon, starting from the rectum. When the disease is confined to the rectum is called ulcerative proctitis (UP). Several studies have unsuccessfully attempted to determine the factors that determine the extent of involvement. The goals of therapy in UP are to induce and maintain remission of symptoms and disease. Topical treatment with 5-aminosalicylates (5-ASA) is the treatment of choice to induce remission. In the maintenance phase, long-term follow up studies suggest that treatment with 5-ASA is better than placebo, to maintain the disease inactive. For those patients that do not respond to treatment with topical 5-ASA or have a moderate to severe disease, there are additional therapies such as oral 5-ASA, topical or systemic corticosteroids, immunomodulators, biological therapies (Infliximab) and cyclosporine. Surgery is seldom needed. |
author |
CASELLI M,GINO PINEDO M,GEORGE ZÚÑIGA D,ÁLVARO ÁLVAREZ L,MANUEL |
author_facet |
CASELLI M,GINO PINEDO M,GEORGE ZÚÑIGA D,ÁLVARO ÁLVAREZ L,MANUEL |
author_sort |
CASELLI M,GINO |
title |
Proctitis ulcerosa activa y refractaria: Una puesta al día |
title_short |
Proctitis ulcerosa activa y refractaria: Una puesta al día |
title_full |
Proctitis ulcerosa activa y refractaria: Una puesta al día |
title_fullStr |
Proctitis ulcerosa activa y refractaria: Una puesta al día |
title_full_unstemmed |
Proctitis ulcerosa activa y refractaria: Una puesta al día |
title_sort |
proctitis ulcerosa activa y refractaria: una puesta al día |
publisher |
Sociedad Médica de Santiago |
publishDate |
2010 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872010000100016 |
work_keys_str_mv |
AT casellimgino proctitisulcerosaactivayrefractariaunapuestaaldia AT pinedomgeorge proctitisulcerosaactivayrefractariaunapuestaaldia AT zunigadalvaro proctitisulcerosaactivayrefractariaunapuestaaldia AT alvarezlmanuel proctitisulcerosaactivayrefractariaunapuestaaldia |
_version_ |
1718436485629214720 |